Related references
Note: Only part of the references are listed.Comparing survival and subsequent treatment of first-line tyrosine kinase inhibitors in patients of advanced lung adenocarcinoma with epidermal growth factor receptor mutation
Ming-Yi Huang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)
Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies First Results From the RCT DUPLICATE Initiative
Jessica M. Franklin et al.
CIRCULATION (2021)
Addressing Extreme Propensity Scores via the Overlap Weights
Fan Li et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2019)
Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
Rishi J. Desai et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
PROPENSITY SCORE WEIGHTING FOR CAUSAL INFERENCE WITH MULTIPLE TREATMENTS
Fan Li
ANNALS OF APPLIED STATISTICS (2019)
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Zhihao Lu et al.
GASTRIC CANCER (2018)
Matching Weights to Simultaneously Compare Three Treatment Groups Comparison to Three-way Matching
Kazuki Yoshida et al.
EPIDEMIOLOGY (2017)
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer
J. A. Ajani et al.
ANNALS OF ONCOLOGY (2017)
Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis
Sabrina M. Ebinger et al.
GASTRIC CANCER (2016)
Advanced gastric cancer: Current treatment landscape and future perspectives
Antonia Digklia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Palliative Gastrectomy Prolongs Survival of Metastatic Gastric Cancer Patients with Normal Preoperative CEA or CA19-9 Values: A Retrospective Cohort Study
Chang-Fang Chiu et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)
M. -H. Ryu et al.
ANNALS OF ONCOLOGY (2015)
Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection
T. Schmidt et al.
EJSO (2015)
Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review
Chun-Ju Chiang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Long-Term Survival in Patients With Metastatic Gastric and Gastroesophageal Cancer Treated With Surgery
Brian Badgwell et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naive patients with advanced gastric cancer
Y. Yamada et al.
ANNALS OF ONCOLOGY (2015)
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2015)
Gastrectomy in Advanced Gastric Cancer Effectively Palliates Symptoms and May Improve Survival in Select Patients
Amy Collins et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2014)
Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
T. Waddell et al.
ANNALS OF ONCOLOGY (2013)
Noncurative Gastrectomy for Gastric Adenocarcinoma Should only be Performed in Highly Selected Patients
Benjamin Schmidt et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Chemotherapy for Advanced Gastric Cancer: Review and Update of Current Practices
Sung Chul Park et al.
GUT AND LIVER (2013)
Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106)
Kuniaki Shirao et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2013)
Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study
Tatsuo Kanda et al.
GASTRIC CANCER (2012)
To resect or not resect in metastatic gastric cancer: that is the question!
Florian Lordick
GASTRIC CANCER (2012)
Changes of Quality of Life after Gastric Cancer Surgery
Horyon Kong et al.
JOURNAL OF GASTRIC CANCER (2012)
Health-related quality of life and survival in the 2 years after surgery for gastric cancer
K. Avery et al.
EJSO (2010)
Chemotherapy for advanced gastric cancer
Anna Dorothea Wagner et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent
Jason S. Gold et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Is there a role for palliative gastrectomy in patients with stage IV gastric cancer?
RF Saidi et al.
WORLD JOURNAL OF SURGERY (2006)
Palliative gastrectomy in advanced gastric cancer: Is it worthwhile?
I Samarasam et al.
ANZ JOURNAL OF SURGERY (2006)
Palliation of metastatic gastric cancer:: Impact of preoperative symptoms and the type of operation on survival and quality of life
V Kahlke et al.
WORLD JOURNAL OF SURGERY (2004)
Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study
P McCulloch et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)